Jardiance (empagliflozin) is one of the most prescribed medicines in the United States for type 2 diabetes and heart failure. It works well. But it is expensive in the United States. Many Americans paying out of pocket ask the same question: Is there a generic drug for Jardiance? The answer right now is No!
As of 2025, there is no FDA-approved generic version of Jardiance in the United States. But that does not mean you are out of options.
This guide may help you find safe, legal, and effective ways to reduce your costs today, with clear steps and practical options.
What Is Jardiance (empagliflozin)?
Jardiance is the brand name for a drug called empagliflozin. It belongs to a group of medicines called SGLT2 inhibitors.
Here is how it works in simple terms: Your kidneys normally filter your blood and send sugar back into it. Jardiance blocks that process. Instead of going back into your blood, the extra sugar leaves your body through urine. This lowers your blood sugar levels safely and consistently.
The U.S. Food and Drug Administration (FDA) has approved Jardiance for three uses. First, it helps control blood sugar in adults with type 2 diabetes. Second, it lowers the risk of heart-related death in adults with type 2 diabetes and heart disease. Third, it reduces hospital visits and death risk in adults with heart failure even those without diabetes.
These three approved uses make Jardiance one of the most clinically valuable medicines in its class. That is also part of why it is so expensive.
Does Jardiance Have A Generic?
In the U.S., no—Jardiance does not have an available generic yet; the brand-name drug is still the only version sold there, and FDA-approved generics are not expected on the U.S. market until at least 2029.
In Canada, Jardiance is generally available as empagliflozin, which is the generic name for the same active ingredient. Candrugstore.com lists both brand-name Jardiance and generic empagliflozin in 10 mg and 25 mg strengths.
Why Are Diabetes Drugs So Expensive?
Without insurance diabetes drugs like Jardiance costs over $600 per month. That is more than $7,000 per year. For Americans managing a long-term condition like diabetes or heart failure, this is a serious financial burden.
No generic Jardiance exists yet. Because of this, federal and state agencies have already stepped in to review its price and push for lower costs. Patents are the biggest reason the price stays this high. They legally block any other company from making a cheaper version of Jardiance until at least 2027 to 2034.
But patents are not the only reason. Here is an overview of what drives the cost of diabetes drugs like Jardiance so high.
The United States has no government law that limits what drug companies can charge for brand-name diabetes drugs. In Canada, the government directly controls and regulates diabetes drug prices. That is why the exact same diabetes drug costs far less in Canada than it does in the U.S. and why so many Americans are now choosing to order diabetes medications through international and Canadian pharmacies.
Jardiance is protected by active patents. These patents give Boehringer Ingelheim the exclusive right to sell it in the United States. No other pharmaceutical company can legally make or sell a cheaper version in the U.S. during this time. With no generic competition, the price remains high for American patients.
A drug like Jardiance undergoes years of research, testing, and FDA approval, costs that are passed directly to American consumers in the final price. On top of this, drug companies direct significant spending toward advertising, further driving up what Americans pay, expenses that are not reflected in the same way in Canadian pricing.
In the U.S., insurers and pharmacy benefit managers (PBMs) work together to set drug prices. They use discounts and rebates. To give these discounts, drug companies keep the list price high. This can make Americans pay more out of pocket. Millions of people need Jardiance for diabetes and heart conditions. This high demand allows the manufacturer to keep prices high.
For many Americans, especially seniors and those on fixed incomes, this cost is hard to afford.
How Does the FDA Approve Generic Drugs?
Before looking at when a generic for Jardiance may become available, it is important to understand how generic drugs get approved.
When a drug’s patent expires, other manufacturers can apply for permission to make a generic version. This application is called an Abbreviated New Drug Application (ANDA). It allows pharmaceutical companies to skip full clinical trials since the drug is already proven safe and effective.
Generic manufacturers must prove bioequivalence. This means the medicine has the same ingredient, same dose, and works the same as the brand-name drug. Once approved, it can be used instead without a new prescription.
Generic drugs make medicine cheaper for many Americans. When a generic for Jardiance becomes available, the price may drop by 70-90%.
Patent and Exclusivity Status of Jardiance
The main reason there is no generic version of Jardiance yet is patent protection. This drug is not protected by just one patent. It is covered by multiple patents.
Each patent protects a different part of the drug. For example, one patent may cover the active ingredient, another may cover how the tablet is made, and another may cover how the drug is used.
This is called Layered Patent Protection. It allows drug companies to extend their exclusivity and delay generic competition.
Because of this, cheaper generic versions cannot enter the market in the United States for many years.
When Will a Generic Jardiance Be Available?
As of 2025, the answer is clear: there is no FDA-approved generic version of Jardiance available in the United States.
If you search online and find websites claiming to sell “generic Jardiance” in the U.S., be careful. They may not contain the right amount of active ingredient, may not meet safety standards, and could put your health at serious risk.
In the United States, Jardiance can be accessed in a few ways. You can pay the full price, which is often over $600 per month without insurance, or use insurance if it covers the medicine.
When Will Jardiance Be Generic?
Jardiance is protected by multiple patents and exclusivity rights, which prevent generic versions from entering the U.S. market until those protections expire. Based on current estimates, the earliest a generic could become available is around 2029, though it could be later — some sources point to patents running as far out as 2034. The exact timing depends on how ongoing patent litigation plays out.
Cost-Saving Strategies Before Generics Arrive
You do not have to wait until 2034 to save money on Jardiance. Several options are available right now. Each works differently, so it is important to pick what fits your health needs and budget best.
Patient Assistance Programs & Manufacturer Coupons
Drug manufacturers offer savings cards and patient assistance programs that can reduce your monthly cost. However, these programs come with strict eligibility rules based on income, insurance status, and citizenship. They can also expire or be discontinued without notice, making them unreliable as a long-term solution.
Insurance
Insurance coverage can lower your cost for diabetes drugs like Jardiance, but plan details vary widely. Even with insurance, you may face high deductibles, co-pays, or find that the medication is not covered under your plan. Coverage can also change year to year, leaving you with unexpected costs. Understanding your plan helps, but it doesn’t guarantee affordable access.
Compare Pharmacy Options
Pharmacy prices for the same medication can vary and comparing local and online pharmacy options may help you find slightly better deals. However, even the lowest U.S. pharmacy prices are often still unaffordable for many patients due to the lack of price regulation.
Brand and Generic Jardiance from a Canadian Online Pharmacy
Unlike the temporary fixes and eligibility barriers of assistance programs, licensed Canadian pharmacies offer consistently affordable prices due to Canada’s government pricing regulations and controlled markups. This makes them the most reliable long-term solution for U.S. patients seeking affordable medications.
By using a trusted licensed online Canadian pharmacy, U.S. patients can safely access generic Jardiance from Canada and abroad at a much lower cost. Through an active CIPA member pharmacy, you can get Jardiance 10mg 100 film-coated tablets for as low as $211. Compare that to U.S. prices of up to $750 for the same quantity. These savings ($539) are consistent and available to everyone regardless of income or insurance status while maintaining full safety and quality standards.
You can buy 10 mg generic Jardiance from a Canadian pharmacy through Candrugstore.com
Comparing Jardiance with Other SGLT2 Inhibitors
Farxiga (dapagliflozin) is one option. It is approved by the FDA for type 2 diabetes and related conditions. A lower-cost version of Farxiga known as dapagliflozin is available in the U.S. and works in a similar way. However, prices in the U.S. can still be around $334 to $625 per month without insurance. Through licensed Canadian pharmacies, you can access the same generic for as low as $38.70 per month making it a far more affordable option for American patients.
The best medicine depends on your health, including heart and kidney conditions. Always talk to your doctor before changing your treatment.
You can buy low cost version of Farxiga online from a Canadian pharmacy through Candrugstore.com
FAQs
Is There a Generic Version of Jardiance Available in the U.S.?
No. As of 2025, there is no generic Jardiance (empagliflozin) available in the United States. The earliest it could arrive is 2027 and only if ongoing patent court cases are resolved in favor of generic makers.
What Is the Cheapest SGLT2 Inhibitor Available Right Now?
Dapagliflozin (the generic version of Farxiga) is currently the most affordable SGLT2 inhibitor in the U.S. Through a licensed Canadian pharmacy, you can get it for as low as $38.70 per month. Ask your doctor if it is the right option for your condition.
Can I use a GoodRx card for Jardiance?
Yes. GoodRx may reduce Jardiance costs at participating pharmacies, and comparing prices across locations may yield some savings. However, discounts vary widely by pharmacy and are not guaranteed, making this an inconsistent solution at best. For Americans seeking stable, predictable savings, a Canadian online pharmacy remains the most reliable and cost-effective alternative for purchasing Jardiance.
Does Medicare Cover Jardiance?
Yes. Many Medicare Part D plans do cover Jardiance and programs like Medicare Extra Help exist to assist those with limited income. However, coverage depends heavily on your plan’s tier and rules, meaning out-of-pocket costs can still be unpredictable and significant. For those who find Medicare coverage falls short, international pharmacies offer a more consistent and affordable way to access Jardiance — without the uncertainty of shifting plan structures.
Is Empagliflozin Available as a Generic in Other Countries?
Yes, empagliflozin is available in some countries outside the United States, depending on local patent laws and approvals.
Conclusion
No Jardiance generic equivalent is available in the U.S. right now. The earliest it may arrive is 2027. Wider availability is more likely between 2028 and 2030.
Affordable options exist today. You can apply for savings programs, check your insurance, compare pharmacy prices, or switch to generic dapagliflozin with your doctor’s help. The easiest and most reliable option is ordering through a licensed Canadian pharmacy.
Always talk to your doctor before changing your medicine or dose. Never skip doses on your own; this can be dangerous.
Until a generic drug for Jardiance reaches the U.S., a licensed Canadian pharmacy gives American patients the most trusted and affordable way to access their medication today.
References
- American Psychological Association (APA). (2025). Diagnostic and statistical manual of mental disorders (5th ed., text rev.). https://www.ncbi.nlm.nih.gov/books/NBK602700/
- Arnold & Porter. (2024, July 10). FTC interim staff report on prescription drug middlemen. https://www.arnoldporter.com/en/perspectives/advisories/2024/07/ftc-interim-staff-report-on-prescription-drug-middlemen
- Assistant Secretary for Planning and Evaluation. (2023). Generic drug competition and prices. https://aspe.hhs.gov/sites/default/files/documents/510e964dc7b7f00763a7f8a1dbc5ae7b/aspe-ib-generic-drugs-competition.pdf
- Assistant Secretary for Planning and Evaluation. (2024). Prescription drug benefits. https://aspe.hhs.gov/topics/prescription-drugs-other-medical-products/health-health-care/prescription-drug-benefits
- Boehringer Ingelheim. (2025). Boehringer Cares patient assistance program application. https://www.boehringer-ingelheim.com/us/about-us/sustainable-development/our-commitment/pdf/boehringer-cares-patient-assistance-program-application
- Centers for Medicare & Medicaid Services. (2024). Medicare drug price negotiation program: Selected drugs and negotiated prices. https://www.cms.gov/priorities/medicare-prescription-drug-affordability/overview/medicare-drug-price-negotiation-program/selected-drugs-negotiated-prices
- Commonwealth Fund. (2025, March). What pharmacy benefit managers do and how they contribute to drug spending.
- Centers for Medicare & Medicaid Services. (n.g.). Costs for Medicare drug coverage. Medicare.gov. https://www.medicare.gov/health-drug-plans/part-d/basics/costs
- https://www.commonwealthfund.org/publications/explainer/2025/mar/what-pharmacy-benefit-managers-do-how-they-contribute-drug-spending
- Congressional Research Service. (2024). Prescription drug pricing: An overview. https://www.congress.gov/crs-product/IF11561
- Dickson, S., & Hernandez, I. (2023). Drugs likely subject to Medicare negotiation, 2026-2028. Journal of Managed Care & Specialty Pharmacy, 29(3), 229–235. https://pubmed.ncbi.nlm.nih.gov/37252071/
- Drugs.com. (2024). Jardiance FDA approval history. https://www.drugs.com/history/jardiance.html
- Drugs.com. (2025a). Generic Farxiga availability. https://www.drugs.com/availability/generic-farxiga.html
- Drugs.com. (2025b). Generic Jardiance availability. https://www.drugs.com/availability/generic-jardiance.html
- European Medicines Agency. (2024). Jardiance: EPAR – product information. https://www.ema.europa.eu/en/medicines/human/EPAR/jardiance
- GoodRx. (2026). How much does Jardiance cost without insurance? https://www.goodrx.com/jardiance/how-much-jardiance-costs-without-insurance
- Gouvernement du Canada. (2006). Comparing Canadian and U.S. prescription drug prices. Canadian Medical Association Journal. https://pmc.ncbi.nlm.nih.gov/articles/PMC1531713/
- GreyB. (2024). Jardiance patent expiration and generic entry. https://pharsight.greyb.com/drug/jardiance-patent-expiration
- KFF. (2025). Key facts about Medicare drug price negotiation. https://www.kff.org/medicare/key-facts-about-medicare-drug-price-negotiation/
- Medical News Today. (2025, February). Does Medicare cover Jardiance? https://www.medicalnewstoday.com/articles/does-medicare-cover-jardiance
- Medical News Today. (2026, January). Jardiance cost: Coupons, insurance, and more. https://www.medicalnewstoday.com/articles/drugs-jardiance-cost
- Medicare.gov. (2025). How drug plans work. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work
- National Institute for Health and Care Excellence. (2022). Type 2 diabetes in adults: Management. https://www.nice.org.uk/guidance/ng28
- Paton, C. (2019). The international spread of SGLT2 inhibitors. BMJ Open. https://pmc.ncbi.nlm.nih.gov/articles/PMC6797030/
- U.S. Food and Drug Administration. (2023). Jardiance (empagliflozin) label. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202293s026lbl.pdf
- U.S. Food and Drug Administration. (2024a). Development & approval process (drugs). https://www.fda.gov/drugs/development-approval-process-drugs
- U.S. Food and Drug Administration. (2024b). Generic drug facts. https://www.fda.gov/drugs/generic-drugs/generic-drug-facts
- U.S. Food and Drug Administration. (2024c). Personal importation. https://www.fda.gov/industry/import-basics/personal-importation
- U.S. Food and Drug Administration. (2024d). SGLT2 inhibitors: Patient safety and information. https://www.fda.gov/media/166151/download
- U.S. Food and Drug Administration. (2025). Farxiga (dapagliflozin) label. https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/204629s063lbl.pdf
- U.S. Government Accountability Office. (2021). Prescription drugs: Many factors can influence prices. https://www.gao.gov/products/gao-21-111
- WebMD. (2025). Jardiance (empagliflozin) oral tablet. https://www.webmd.com/drugs/jardiance-empagliflozin
